Journey Medical Corp. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1286808,
    "name": "Journey Medical Corp.",
    "stock_name": "Journey Medical Corp.",
    "full_name": "Journey Medical Corp.",
    "name_url": "stocks-analysis/journey-medical-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.81",
    "chg": 0.4,
    "chgp": "5.4%",
    "dir": 1,
    "prev_price": "7.41",
    "mcapval": "184.43",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US48115J1097",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "153.66 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/journey-medical-corp-1286808-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corps-financial-trend-improves-from-flat-to-positive-amid-rising-sales-and-cash-flow-3715758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_fintrenddot_3715758.png",
        "date": "2025-11-19 15:49:56",
        "description": "Journey Medical Corp. has reported flat financial performance for the quarter ending June 2025, with strong revenue generation reflected in net sales of USD 15.01 million and improved operating cash flow. However, rising interest expenses and declines in pre-tax and net profit indicate ongoing profitability challenges. The stock has significantly outperformed the S&P 500 year-to-date."
      },
      {
        "title": "Journey Medical Corp. Hits New 52-Week High of $9.40",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corp-hits-new-52-week-high-of-940-3698054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_priceRelatedfactors_3698054.png",
        "date": "2025-11-13 16:09:27",
        "description": "Journey Medical Corp. achieved a new 52-week high of USD 9.40 on November 12, 2025, reflecting a significant increase from its low of USD 3.54. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently loss-making and does not offer dividends."
      },
      {
        "title": "Journey Medical Corp. Hits New 52-Week High of $9.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corp-hits-new-52-week-high-of-938-3693011",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_priceRelatedfactors_3693011.png",
        "date": "2025-11-12 16:15:22",
        "description": "Journey Medical Corp. achieved a new 52-week high of USD 9.38 on November 11, 2025, reflecting a significant performance increase over the past year. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently operating at a loss."
      },
      {
        "title": "Journey Medical Corp. Hits New 52-Week High of $9.01",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corp-hits-new-52-week-high-of-901-3674059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_priceRelatedfactors_3674059.png",
        "date": "2025-11-05 16:51:19",
        "description": "Journey Medical Corp. achieved a new 52-week high of USD 9.01 on November 4, 2025, reflecting a strong one-year performance. The company, with a market cap of USD 184 million, has a negative return on equity and a low debt-to-equity ratio, indicating financial stability amid industry challenges."
      },
      {
        "title": "Is Journey Medical Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-journey-medical-corp-technically-bullish-or-bearish-3547794",
        "imagepath": "",
        "date": "2025-09-20 20:03:16",
        "description": "As of 29 August 2025, the technical trend for Journey Medical Corp. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are mildly bearish, while the monthly MACD and KST are bullish. The daily moving averages indicate a mildly bullish stance, and the Bollinger Bands show a bullish trend on the monthly timeframe. However, both the weekly and monthly Dow Theory and OBV indicate no trend. \n\nIn terms of performance, Journey Medical Corp. has outperformed the S&P 500 significantly year-to-date with a return of 85.93% compared to the S&P 500's 12.22%. Over the past year, the stock also shows a strong return of 41.99% against the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, driven by the monthly bullish indicators and strong multi-period returns...."
      },
      {
        "title": "Is Journey Medical Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-journey-medical-corp-overvalued-or-undervalued-3544053",
        "imagepath": "",
        "date": "2025-09-20 18:36:20",
        "description": "As of 12 November 2024, the valuation grade for Journey Medical Corp. has moved from fair to risky, indicating a deteriorating outlook. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 7.99 and a troubling EV to EBITDA ratio of -22.82. Additionally, the Return on Capital Employed (ROCE) stands at -44.88%, reflecting significant inefficiencies in generating returns from capital investments.\n\nIn comparison to peers, Journey Medical Corp.'s valuation ratios are less favorable; for instance, Fortress Biotech, Inc. has a more manageable EV to EBITDA of -0.87, while Sol-Gel Technologies Ltd. shows an EV to EBITDA of -11.11. Despite the company's strong year-to-date return of 85.93% compared to the S&P 500's 12.22%, the overall financial health suggests that the stock is not a sound investment at its current price of 7.27...."
      }
    ],
    "total": 10,
    "sid": "1286808",
    "stock_news_url": "https://www.marketsmojo.com/news/journey-medical-corp-1286808"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators

2025-11-19 15:49:56

Journey Medical Corp. has reported flat financial performance for the quarter ending June 2025, with strong revenue generation reflected in net sales of USD 15.01 million and improved operating cash flow. However, rising interest expenses and declines in pre-tax and net profit indicate ongoing profitability challenges. The stock has significantly outperformed the S&P 500 year-to-date.

Journey Medical Corp. Hits New 52-Week High of $9.40

2025-11-13 16:09:27

Journey Medical Corp. achieved a new 52-week high of USD 9.40 on November 12, 2025, reflecting a significant increase from its low of USD 3.54. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently loss-making and does not offer dividends.

Journey Medical Corp. Hits New 52-Week High of $9.38

2025-11-12 16:15:22

Journey Medical Corp. achieved a new 52-week high of USD 9.38 on November 11, 2025, reflecting a significant performance increase over the past year. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently operating at a loss.

Journey Medical Corp. Hits New 52-Week High of $9.01

2025-11-05 16:51:19

Journey Medical Corp. achieved a new 52-week high of USD 9.01 on November 4, 2025, reflecting a strong one-year performance. The company, with a market cap of USD 184 million, has a negative return on equity and a low debt-to-equity ratio, indicating financial stability amid industry challenges.

Is Journey Medical Corp. technically bullish or bearish?

2025-09-20 20:03:16

As of 29 August 2025, the technical trend for Journey Medical Corp. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are mildly bearish, while the monthly MACD and KST are bullish. The daily moving averages indicate a mildly bullish stance, and the Bollinger Bands show a bullish trend on the monthly timeframe. However, both the weekly and monthly Dow Theory and OBV indicate no trend. In terms of performance, Journey Medical Corp. has outperformed the S&P 500 significantly year-to-date with a return of 85.93% compared to the S&P 500's 12.22%. Over the past year, the stock also shows a strong return of 41.99% against the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, driven by the monthly bullish indicators and strong multi-period returns....

Is Journey Medical Corp. overvalued or undervalued?

2025-09-20 18:36:20

As of 12 November 2024, the valuation grade for Journey Medical Corp. has moved from fair to risky, indicating a deteriorating outlook. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 7.99 and a troubling EV to EBITDA ratio of -22.82. Additionally, the Return on Capital Employed (ROCE) stands at -44.88%, reflecting significant inefficiencies in generating returns from capital investments. In comparison to peers, Journey Medical Corp.'s valuation ratios are less favorable; for instance, Fortress Biotech, Inc. has a more manageable EV to EBITDA of -0.87, while Sol-Gel Technologies Ltd. shows an EV to EBITDA of -11.11. Despite the company's strong year-to-date return of 85.93% compared to the S&P 500's 12.22%, the overall financial health suggests that the stock is not a sound investment at its current price of 7.27....

View All News